Zoetis Inc.
WHO'M
ai
Digital Profiler. Simply click the AI button
FIGI: BBG0039320N9
ZTS
Zoetis Inc.
GICS: 35202010
·
Sector: Healthcare
·
Sub-Sector: Drug Manufacturers—Specialty & Generic
NAME
Zoetis Inc.
ISIN
US98978V1035
TICKER
ZTS
MIC
XNYS
REUTERS
ZTS.N
BLOOMBERG
ZTS US
F&G:
58
Financial Intelligence
FOR INVESTORS
FOR TRADERS
Securities Trading
Warrants
The X-News Explorer is the ultimate source of information for investors with an affinity for the stock market who want to get a quick and convenient overview of the current news situation of a listed company. Various newswire services are available to you here. If a news alert is displayed, you will find company news that may be of interest to you. This service is provided by BusinessWire.
Tue, 06.05.2025
Zoetis
US98978V1035
Zoetis Inc. (NYSE:ZTS) today reported its financial results for the first quarter of 2025 and updated its full year 2025 guidance.
The company reported revenue of $2.2 billion for the first quarter of 2025, an increase of 1% compared with the first quarter of 2024. On an organic operational1 basis, revenue for the first quarter of 2025 increased ...
Thu, 27.03.2025
Zoetis
US98978V1035
Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Tuesday, May 6, 2025. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review first quarter 2025 financial results and respond to questions from financial analysts during the call.
Investors and the ...
Thu, 20.02.2025
Zoetis
US98978V1035
Zoetis Inc. (NYSE:ZTS) today announced that a representative from the company will participate in the following investor conferences.
Bank of America Securities 2025 Animal Health Summit on Thursday, February 27, 2025 at 1:20 p.m. ET.
Barclays Global Healthcare Conference on Tuesday, March 11, 2025 at 10:30 a.m. ET.
Investors and other inter...
Fri, 14.02.2025
Zoetis
US98978V1035
Zoetis today announced that the U.S. Department of Agriculture (USDA), Center for Veterinary Biologics (CVB) has issued the company a conditional license for its Avian Influenza Vaccine, H5N2 Subtype, Killed Virus. The vaccine is labelled for use in chickens. The conditional license was granted on the demonstration of safety, purity, and reasonabl...
Thu, 13.02.2025
Zoetis
US98978V1035
Zoetis Inc. (NYSE: ZTS) today reported its financial results for the fourth quarter and full year 2024 as well as provided full year guidance for 2025.
The company reported revenue of $2.3 billion for the fourth quarter of 2024, an increase of 5% compared with the fourth quarter of 2023. On an operational1 basis, revenue for the fourth quarter o...
Thu, 06.02.2025
Zoetis
US98978V1035
The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.50 per share for the second quarter of 2025. The dividend will be paid on Tuesday, June 3, 2025, to all holders of record of the Company’s common stock as of the close of business on Monday, April 21, 2025.
About Zoetis
As the world’s leading animal health company, ...
Tue, 04.02.2025
Zoetis
US98978V1035
Zoetis Inc. today announced that it has updated the U.S. label for Librela® (bedinvetmab injection), following its submission of a supplement to the U.S. Food and Drug Administration (FDA). This supplement includes updated labeling based on post-approval experience with Librela in the U.S. since the product launched over a year ago. The company re...
Tue, 07.01.2025
Zoetis
US98978V1035
Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, February 13, 2025. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review fourth quarter and full year 2024 financial results and respond to questions from financial analysts during the cal...
Thu, 12.12.2024
Zoetis
US98978V1035
The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.50 per share for the first quarter of 2025, an increase of 16% from the quarterly dividend rate paid in 2024. The dividend will be paid on Tuesday, March 4, 2025, to all holders of record of the Company’s common stock as of the close of business on Tuesday, January 21, ...
Tue, 19.11.2024
Zoetis
US98978V1035
Zoetis Inc. (NYSE:ZTS) will participate in the Piper Sandler 36th Annual Healthcare Conference on Tuesday, December 3, 2024. Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts at 11:30 a.m. ET.
Investors and other interested parties will be able to access a live...
Information on product placements
SMART * AD
P R O D U C T S U G G E S T I O N S
